These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3078958)

  • 21. Alternative splicing of the chicken c-myb exon 9A.
    Schuur ER; Dasgupta P; Reddy EP; Rabinovich JM; Baluda MA
    Oncogene; 1993 Jul; 8(7):1839-47. PubMed ID: 8510928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In situ and in vitro evidence for intragenic binding of nuclear factors at the murine c-myc locus.
    Tourkine N; Mechti N; Piechaczyk M; Jeanteur P; Blanchard JM
    Oncogene; 1989 Aug; 4(8):973-8. PubMed ID: 2548146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetic characterization of epitope-specific monoclonal antibodies against the myc family proteins.
    Ikegaki N; Kennett RH
    Oncogene; 1990 Mar; 5(3):397-403. PubMed ID: 1690381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
    Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
    Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
    Lavialle C; Modjtahedi N; Cassingena R; Brison O
    Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.
    Brownell E; Mittereder N; Rice NR
    Oncogene; 1989 Jul; 4(7):935-42. PubMed ID: 2666912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental regulation of translation by the 5' noncoding region of murine c-myc mRNA in Xenopus laevis.
    Lazarus P; Parkin N; Sonenberg N
    Oncogene; 1988 Nov; 3(5):517-21. PubMed ID: 3078957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the complete human c-fgr proto-oncogene and identification of multiple transcriptional start sites.
    Patel M; Leevers SJ; Brickell PM
    Oncogene; 1990 Feb; 5(2):201-6. PubMed ID: 1690869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a second promoter in the human c-myb proto-oncogene.
    Jacobs SM; Gorse KM; Westin EH
    Oncogene; 1994 Jan; 9(1):227-35. PubMed ID: 8302584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV; Kukowska J
    Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative splicing in protein associated with Myc (Pam) influences its binding to c-Myc.
    Santos TM; Han S; Bowser M; Sazani K; Beauchamp RL; Murthy V; Bhide PG; Ramesh V
    J Neurosci Res; 2006 Feb; 83(2):222-32. PubMed ID: 16342205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
    Gauthier ER; Piché L; Lemieux G; Lemieux R
    Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
    Eager KB
    Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene.
    Mäkelä TP; Saksela K; Alitalo K
    Mol Cell Biol; 1989 Apr; 9(4):1545-52. PubMed ID: 2657399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and characterization of a protein encoded by the human c-myc exon 1 in Escherichia coli.
    Psallidopoulos MC; Seth A; Dubois GC; Fisher RJ; Papas TS
    Gene Anal Tech; 1989; 6(3):47-56. PubMed ID: 2524439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis of the protein encoded by the c-met proto-oncogene.
    Giordano S; Di Renzo MF; Narsimhan RP; Cooper CS; Rosa C; Comoglio PM
    Oncogene; 1989 Nov; 4(11):1383-8. PubMed ID: 2554238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.